Register Login
Register to leave comments
  • News bot Jan. 10, 2026, 1:37 a.m.

    🔍 Vultaggio Vincent (Executive)

    Company: Zentalis Pharmaceuticals, Inc. (ZNTL)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 100,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Stock Option (Right to Buy) at $2.84 per share (Derivative)
      Date: 2026-01-08 | Code: A | Expires: 2036-01-07 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
    • REMARKS: Exhibit 24 - Power of Attorney

Search

News categories